CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Laboratory-based vestibular function testing (ENG/VNG, caloric, rotational chair, VEMP)

This policy defines medical necessity and coverage for laboratory-based vestibular function tests (ENG/VNG test batteries, caloric testing, rotational chair testing) and vestibular evoked myogenic potential (VEMP) testing for Medicare Advantage and Commercial products offered by Blue Cross Blue Shield - Rhode Island. It states coverage when symptoms persist after clinical evaluation and noncoverage/not medically necessary determinations for VEMP and other unspecified laboratory tests.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyLaboratory-based vestibular function testing (ENG/VNG, caloric, rotational chair, VEMP)

Policy CodePolicy N/A

Change TypeNo material changes

Effective Date

Next Review Date

Key ActionProviders must document that a clinical evaluation, including maneuvers such as the Dix-Hallpike test when indicated, failed to identify the cause of symptoms before laboratory-based vestibular testing is considered medically necessary.

SourceLink

POLICY UPDATE CHANGES

No material clinical/coverage changes

9CPT codes listed

3CPT codes not covered (VEMP)

2Product lines

Coverage Summary

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

This policy covers laboratory-based vestibular function testing for individuals with suspected vestibular disorders. Coverage is mixed: ENG/VNG test batteries, caloric testing, and rotational chair testing are considered medically necessary when clinical evaluation (including maneuvers such as the Dix-Hallpike when indicated) fails to identify the cause of symptoms; vestibular evoked myogenic potential (VEMP) testing is designated not covered / not medically necessary due to insufficient evidence.

Quick facts from brief

Product linesMedicare Advantage, Commercial

CPT codes listed9

CPT codes not covered (VEMP)3

Policy scope summaryDefines medical necessity and coverage for laboratory-based vestibular function tests (ENG/VNG, caloric, rotational chair) and VEMP testing for Medicare Advantage and Commercial products; covers established tests when symptoms persist after clinical evaluation and deems VEMP and other unspecified lab tests not covered/not medically necessary.

Medical-Necessity Criteria

Medicare Advantage Plans - Medically Necessary Criteria

Vestibular function testing is considered medically necessary when ALL of the following are met:

ALL of the following

Individual has symptoms of a vestibular disorder (eg, dizziness, vertigo, imbalance)
A clinical evaluation, including maneuvers such as the Dix-Hallpike test if indicated, has failed to identify the cause of the symptoms
Testing performed is one of the established laboratory-based tests: ENG/VNG test batteries, caloric testing, or rotational chair testing

Commercial Products - Medically Necessary Criteria

Vestibular function testing is considered medically necessary when ALL of the following are met:

ALL of the following

Individual has symptoms of a vestibular disorder (e.g., dizziness, vertigo, imbalance)
A clinical evaluation, including maneuvers such as the Dix-Hallpike test if indicated, has failed to identify the cause of the symptoms
Testing performed is one of the established laboratory-based tests: ENG/VNG test batteries, caloric testing, or rotational chair testing

Not Medically Necessary / Not Covered

The following are considered not covered/not medically necessary:

ANY of the following

Vestibular function testing for the assessment of typical benign paroxysmal positional vertigo (BPPV) that can be diagnosed clinically
Repeat vestibular function testing when treatment resolves symptoms
Laboratory-based vestibular function tests not described above (i.e., tests other than ENG/VNG, caloric, rotational chair) as evidence is insufficient
ANY of the following
- 92517 Vestibular evoked myogenic potential (cVEMP) - NOT COVERED / NOT MEDICALLY NECESSARY

Provider Actions & Billing Impact

Documentation Required

Document clinical evaluation and maneuvers

Providers must document that a clinical evaluation, including maneuvers such as the Dix-Hallpike test when indicated, failed to identify the cause of symptoms before laboratory-based vestibular testing is considered medically necessary.

Include Dix-Hallpike maneuver when indicated

Denial Risk

Claims for VEMP testing at risk of denial

Claims for CPT codes 92517, 92518, or 92519 are considered not covered / not medically necessary and may be denied.

92517
92518
92519

Background & Evidence

The vestibular system includes five end organs — three semicircular canals that sense head rotations and two otolith organs (saccule and utricle) that sense gravity and linear acceleration — and is a key component in balance control. Vertigo and imbalance may arise from peripheral (labyrinth, vestibular nerve) or central (brainstem) causes.

Benign paroxysmal positional vertigo (BPPV) is commonly caused by loose otoconia entering a semicircular canal (most often the posterior canal). BPPV is typically diagnosed clinically from a compatible history, positional testing such as the Dix-Hallpike or lateral roll tests, and resolution of symptoms with canalith repositioning maneuvers; laboratory testing generally does not add diagnostic value in typical BPPV.

When vertigo cannot be attributed to BPPV by history or standard maneuvers, laboratory-based tests based on the vestibulo-ocular reflex may help distinguish central versus peripheral causes and unilateral versus bilateral deficits. Established tests include ENG/VNG test batteries (oculomotor and positional testing; ENG uses electrodes and VNG uses infrared video goggles), caloric testing (warm or cold irrigation of each external ear canal to evaluate unilateral function), and rotational chair testing (computer-driven chair to assess bilateral vestibular function).

VEMP testing (cervical and ocular) uses loud sounds or bone vibration to assess otolith function; however, evidence on diagnostic accuracy and clinical utility is currently insufficient to determine health outcome benefits, so VEMP is not considered covered.

Key evidence notes

Caloric and rotational chair testing recommendationLevel A (predictive of loss of vestibular function / criterion standard tests)

VEMP evidenceInsufficient to determine effects on health outcomes; mainly association studies

BPPV: Typically diagnosed clinically based on history, the Dix-Hallpike or lateral roll tests, and response to canalith repositioning maneuvers.

ENG/VNG: Electronystagmography (ENG) uses electrodes to detect nystagmus; videonystagmography (VNG) uses infrared video monitoring to measure nystagmus; test batteries include oculomotor evaluation and positional testing.

VEMP: Vestibular evoked myogenic potentials (cVEMP, oVEMP) use sound or vibration to assess otolith function; cervical VEMP is measured from the sternocleidomastoid and ocular VEMP from electrodes under the eye.